Healthtech Startups
15,470 companies tagged Healthtech, with their investors and founders.
Perseus Proteomics (PPMX) is a Japanese biotech company that uses proprietary antibody technology to develop new antibody-based drugs. It also provides antibody research support services and sells antibodies and reagents, including PTX3 measurement kits.
5 investors
Persimmon is a platform that connects individuals with nearby registered nurses offering aesthetic and wellness treatments, such as Botox and health assessments, delivered in a private in-home setting. Users can browse provider profiles with bios, reviews, and photos, book consultations, and receive personalized wellness plans.
5 investors
A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.
5 investors
5 investors
Piramidal bridges in-vivo and in-silico intelligence for neuroscience research and clinical applications. The company develops technology that integrates biological data with computational intelligence.
5 investors
Plantiga develops wearable insole technology with integrated sensors for gait analytics and movement health monitoring. The company serves consumers and athletes seeking to improve their movement and overall health outcomes.
5 investors
Plenful is an AI platform that automates complex administrative workflows in pharmacy operations, designed for healthcare organizations and pharmacy teams. The company aims to reduce manual inefficiencies, errors, and delays in patient care delivery through intelligent automation built by former pharmacy operators and AI engineers.
5 investors
Postera uses artificial intelligence and computational chemistry to accelerate drug discovery for pharmaceutical companies. The platform combines machine learning, medicinal chemistry, and software engineering to improve the drug development process.
5 investors
Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression. The company leverages expertise in mitochondrial biology and drug discovery to create treatments for diseases associated with mitochondrial dysregulation.
5 investors
Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax. Acquired by Lundbeck in 2018.
5 investors
Prime Medicine develops one-time genetic therapies using Prime Editing, a gene editing technology developed in David R. Liu's lab at the Broad Institute of MIT and Harvard. The company aims to treat a broad range of genetic diseases.
5 investors
Probius develops Quantum Electrochemical Spectroscopy (QES), a label- and reagent-free electrochemical sensing technology that detects and quantifies thousands of analytes—proteins, metabolites, and cells—from microliter-scale biological samples in about 30 minutes. The platform generates digital representations of biological specimens and cloud-based multiplex assays intended to feed AI models of biology for biomarker discovery, drug development, and bioproduction quality control.
5 investors
Proov offers at-home hormone and fertility testing products, including systems to identify the fertile window, confirm ovulation, and screen for leading causes of infertility, paired with an app providing hormone insights and personalized recommendations. It serves women tracking their fertility and reproductive wellness.
5 investors
Proteinea uses proprietary AI models and computational tools to engineer antibodies, focusing on rational design of antibody Fc domains for improved efficacy, half-life, and targeted biodistribution. It combines AI-driven design frameworks with wet-lab validation to develop Fc-optimized antibody scaffolds for therapeutic development.
5 investors
Puzzle Medical develops a heart failure treatment device designed to improve heart and kidney function through 4Fr axillary access, allowing patient ambulation and providing up to seven days of support. The technology targets early and safe treatment of heart failure.
5 investors
Q32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis. The company was formed through a merger with Homology Medicines in 2024 and is led by a team with immunology and biopharmaceutical drug development experience.
5 investors
QSM Diagnostics develops point-of-care veterinary diagnostics for the rapid identification of bacterial infections. The company, a spinout of the Goluch Research Group at Northeastern University, builds sensors and medical devices for the veterinary market.
5 investors
Qualifyze offers a centralized audit management platform for life sciences supply chains, letting quality and procurement teams plan, execute, and track supplier GxP audits globally with integrated CAPA tracking. It also provides access to a large library of ready-to-use GxP audit reports to speed up supplier qualification and compliance.
5 investors
Qventus provides operations management software for hospitals and healthcare systems to address clinical inefficiencies and reduce clinician burnout. The platform helps healthcare providers optimize their operational workflows across clinical, technological, and regulatory functions.
5 investors
Radical Health develops technology in the medical and healthcare sector. The company is led by a founder with expertise in mathematical oncology and mathematics.
5 investors
Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health. It works in high-throughput laboratory sciences.
5 investors
Stryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
5 investors
ReadySet provides surgical supply chain management software for hospitals, helping healthcare teams reduce delays, cut costs, and optimize surgical case workflows.
5 investors
Redox provides healthcare data integration infrastructure that enables organizations to ingest EHR and legacy data into cloud-based clinical repositories and third-party healthcare applications. The company partners with cloud providers, system integrators, and healthcare solution vendors to facilitate interoperability for healthcare enterprises and technology developers.
5 investors